WebQA and Regulatory Leader with extensive experience in Medical Devices, Pharmaceutical and Biotech IndustrySpecialties: Medical Devices, Combination Products, Connected Care, SaMD, Contract... WebChristine Öberg’s Post Christine Öberg Advisor Medical Device at SDS MedteQ 4y
MDR Article 117: Implications for Drug-device Combination Products
WebJul 6, 2015 · Knowledge in compilation and submission of technical file/dossier to Notified bodies to obtain Notified Body Opinion (NBOp) for drug-device combination products. Currently, I'm handling... WebSep 12, 2024 · 250 €. 4000 € *. 100 €. link. Data marked * are obtained through customers feedback. The NSAI rates were communicated directly by the NSAI to Qualitiso. UDEM and MED-CERT are the most compliant notified bodies, with clear fee detail and consideration of company size 👍. Guillaume Promé: Qualitiso Founder • Expert in medical devices ... slow cpu slow streaming
Drug-device combination products - BSI Group
WebSep 8, 2024 · As of August 2024, there were 22 Notified Bodies which can engage in the review of medical devices under the MDR. This represents a significant reduction in the number of these entities previously operating under the MDD (>75 NBs). This considerable capacity reduction for a key stakeholder is a potential hurdle for the sector going forward. WebBSI issued first Article 117 Notified Body Opinion BSI was the first ever Notified Body to issue a NBOp to a manufacturer for a drug-device combination product under MDR Article … WebMar 10, 2024 · Obtaining a Notified Body Opinion (NBOp) will require a significant investment of time and resources. If not addressed correctly, the process may directly … slow covid response